Sign in or 
- EasyEdit
- Edit tags
-
(what's this?What are these tools?
People just like you can add or edit the content on this site. If you want to try editing, but aren't ready to add to this site, try our demo area.
Read more about editing pages at Wetpaint Central.
) - Report page
Share this
Biocryst, Green Cross entering Korean Peramivir License deal
Biocryst, Green Cross entering Korean Peramivir License deal
BioWorld Today
June 15, 2006
As the avian flu continues to move through Asia and threaten the rest of the world, BioCryst Pharmaceuticals Inc.'s Phase I neuraminidase inhibitor garnered a licensing deal with Green Cross Corp. in Korea, where testing of peramivir will yield data to supplement the U.S. results.
Visit the above link to read the rest of the article.
BioWorld Today
June 15, 2006
As the avian flu continues to move through Asia and threaten the rest of the world, BioCryst Pharmaceuticals Inc.'s Phase I neuraminidase inhibitor garnered a licensing deal with Green Cross Corp. in Korea, where testing of peramivir will yield data to supplement the U.S. results.
Visit the above link to read the rest of the article.
|
Sally |
Latest page update: made by Sally
, Jun 15 2006, 12:20 AM EDT
(about this update
About This Update
new article: Biocryst
- Sally
69 words added view changes - complete history) |
|
Keyword tags:
avian flu
bird flu
H5N1
Korea
pharmaceutical
Relenza
Tamiflu
U.S.
WHO
(edit keyword tags)
More Info: links to this page
|
There are no threads for this page.
Be the first to start a new thread.
